Dr. Sudeep Khanna

Professional Summary

Dr. Sudeep Khanna is a highly regarded Gastroenterologist and GI Medicine Specialist based in South Delhi, India, with an impressive 19+ years of experience in the field. He has dedicated his career to diagnosing and treating a wide range of gastrointestinal disorders, with special interests in Irritable Bowel Syndrome, Fatty Liver, and Obesity. Dr. Khanna is well-qualified, holding MBBS, MD, and DM degrees, which equip him with in-depth knowledge and expertise in gastroenterology. Dr. Khanna is fluent in both English and Hindi, ensuring effective communication with a diverse patient population. His commitment to patient care and his extensive experience have earned him respect among his peers and patients alike. He specializes in liver and intestinal diseases and is proficient in all endoscopic procedures, making him a trusted choice for individuals seeking expert evaluation and management of gastrointestinal health concerns. He is presently serving as a Senior Consultant Gastroenterologist at Apollo Indraprastha Hospital, New Delhi, one of India's premier healthcare institutions.

Specializations

- Gastroenterology & Hepatobiliary
- Medical Gastroenterology
- Hepatology

Procedures & Expertise

- Therapeutic Endoscopy
- ERCP
- Endoscopic Dilatation
- Endoscopic Hemostasis
- Advanced Polypectomy
- Peptic Ulcer Disease
- Non-Alcoholic Fatty Liver Disease
- Chronic Liver Disease
- Inflammatory Bowel Disease
- Gastroesophageal Reflux Disease
- Severe Functional GI Disorders
- GI Stenting

Education & Qualifications

- MBBS
- MD
- DM (Gastroenterology)

Hospital Affiliations

- Apollo Indraprastha Hospital, New Delhi
- PSRI – Pushpawati Singhania Hospital

Memberships

- Medical Council of India (Registration No. 11091)
- Delhi Medical Council (Registration No. 20281)
- Indian Society of Gastroenterology

Awards & Recognition

- Invited Speaker to various Meetings of State Medical Associations

Research & Publications

- Grover G, Sreenivas V, Khanna S, Seth D. "Estimation of Survival of Liver Cirrhosis Patients, in the Presence of Prognostic Factors Using Accelerated Failure Time Model as an Alternative to Proportional Hazard Model." International Journal of Statistics and Applications, 2013; 3(4): 113-1222. - Koné-Paut I, Lachmann HJ, Kuemmerle-Deschner JB, Hachulla E, Leslie KS, Mouy R, Ferreira A, Lheritier K, Patel N, Preiss R, Hawkins PN. “Canakinumab in CAPS Study Group.” Arthritis Res Ther.